Ashish A. Kulkarni, Ph.D.

2011 Chemistry University of Cincinnati, Cincinnati, OH 
Biochemistry, Analytical Chemistry
"Ashish Kulkarni"


Sign in to add mentor
Suri S. Iyer grad student 2011 University of Cincinnati
 (Tailored glycans for the precise detection of toxins and pathogens.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kumar S, Ramesh A, Kulkarni A. (2020) Targeting macrophages: a novel avenue for cancer drug discovery. Expert Opinion On Drug Discovery. 1-14
Ramesh A, Kumar S, Nguyen A, et al. (2020) Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy. Nanoscale
Ramesh A, Natarajan SK, Nandi D, et al. (2019) Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor. Cellular and Molecular Bioengineering. 12: 357-373
Ramesh A, Brouillard A, Kumar S, et al. (2019) Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy. Biomaterials. 227: 119559
Ramesh A, Kumar S, Nandi D, et al. (2019) CSF1R- and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages. Advanced Materials (Deerfield Beach, Fla.). e1904364
Kulkarni A, Chandrasekar V, Natarajan SK, et al. (2018) A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. Nature Biomedical Engineering. 2: 589-599
Roy M, Krishna V, Sengupta A, et al. (2018) Abstract 4712: AT1965, a novel B cell-activating immunotherapy, exerts potent anticancer activity Cancer Research. 78: 4712-4712
Ismail N, Kulkarni A, Kumar S, et al. (2017) Abstract 4610: Towards understanding the cellular uptake patterns of nano-particles among different immune cell lines Cancer Research. 77: 4610-4610
Kulkarni A, Natarajan SK, Chandrasekar V, et al. (2016) Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anti-Cancer Efficacy. Acs Nano
Goldman A, Kulkarni A, Kohandel M, et al. (2016) Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer. Acs Nano
See more...